Vinay Garg

1.3k total citations · 1 hit paper
20 papers, 727 citations indexed

About

Vinay Garg is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Vinay Garg has authored 20 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Vinay Garg's work include Diabetes Treatment and Management (8 papers), Aortic Disease and Treatment Approaches (5 papers) and Cardiovascular Function and Risk Factors (5 papers). Vinay Garg is often cited by papers focused on Diabetes Treatment and Management (8 papers), Aortic Disease and Treatment Approaches (5 papers) and Cardiovascular Function and Risk Factors (5 papers). Vinay Garg collaborates with scholars based in Canada, United Kingdom and United States. Vinay Garg's co-authors include Subodh Verma, Kim A. Connelly, Adrian Quan, Hwee Teoh, Andrew T. Yan, C. David Mazer, Mohammed Al‐Omran, Peter Jüni, Bernard Zinman and Richard E. Gilbert and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Vinay Garg

19 papers receiving 717 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

2019 386 citations Subodh Verma, C. David Mazer et al. Circulation profile →

Peers

Countries citing papers authored by Vinay Garg

Since Specialization

Citations

This map shows the geographic impact of Vinay Garg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinay Garg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinay Garg more than expected).

Fields of papers citing papers by Vinay Garg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinay Garg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinay Garg. The network helps show where Vinay Garg may publish in the future.

Co-authorship network of co-authors of Vinay Garg

This figure shows the co-authorship network connecting the top 25 collaborators of Vinay Garg. A scholar is included among the top collaborators of Vinay Garg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinay Garg. Vinay Garg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sodium‐Glucose Cotransporter 2 Inhibitors, All‐Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta‐Analysis and Meta‐Regression 2021 ·Journal of the American Heart Association ·Ayodele Odutayo, Bruno R. da Costa, Tiago Pereira, Vinay Garg, (unknown), (unknown), (unknown), Cesar A. Hincapié, (unknown), Myanca Rodrigues, Arnav Agarwal, (unknown), Pakeezah Saadat, Jacob A. Udell, Francesco Cosentino, Peter J. Grant, Subodh Verma, Peter Jüni	18
2	Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes 2021 ·Cardiovascular Diabetology ·(unknown), Subodh Verma, C. David Mazer, Hwee Teoh, Adrian Quan, Richard E. Gilbert, Shaun G. Goodman, (unknown), Otávio R. Coelho‐Filho, (unknown), Djeven P. Deva, Vinay Garg, Sumeet Gandhi, Kim A. Connelly, Andrew T. Yan	23
3	The effects of saxagliptin on cardiac structure and function using cardiac MRI (SCARF) 2021 ·Acta Diabetologica ·Paul Sandhu, (unknown), Vinay Garg, (unknown), (unknown), (unknown), Subodh Verma, Andrew T. Yan, Kim A. Connelly	5
4	Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis 2020 ·SHILAP Revista de lepidopterología ·Vinay Garg, Subodh Verma, Kim A. Connelly, Andrew T. Yan, (unknown), Ankit Garg, Paul Dorian, Fei Zuo, Lawrence A. Leiter, Bernard Zinman, Peter Jüni, Atul Verma, Hwee Teoh, Adrian Quan, C. David Mazer, Andrew C.T. Ha	19
5	Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes 2019 ·Progress in Cardiovascular Diseases ·Vinay Garg, Subodh Verma, Kim A. Connelly	54
6	Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice 2019 ·The Lancet Diabetes & Endocrinology ·Ankit Garg, Vinay Garg, Robert A. Hegele, Gary F. Lewis	18
7	P3753Does empagliflozin modulate the autonomic system among patients with type 2 diabetes and coronary artery disease? Insights from the Holter sub-study of the EMPA-Heart CardioLink-6 Randomised Trial 2019 ·European Heart Journal ·Vinay Garg, Subodh Verma, Kim A. Connelly, Andrew T. Yan, (unknown), Amit X. Garg, Paul Dorian, Fei Zuo, Lawrence A. Leiter, Bernard Zinman, Peter Jüni, Atul Verma, Adrian Quan, C. David Mazer, Andrew C.T. Ha	1
8	Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease breakdown → 2019 ·Circulation ·Subodh Verma, C. David Mazer, Andrew T. Yan, Tamique Mason, Vinay Garg, Hwee Teoh, Fei Zuo, Adrian Quan, Michael E. Farkouh, David Fitchett, Shaun G. Goodman, Ronald Goldenberg, Mohammed Al‐Omran, Richard E. Gilbert, Deepak L. Bhatt, Lawrence A. Leiter, Peter Jüni, Bernard Zinman, Kim A. Connelly, (unknown)	386
9	P1500Effects of empagliflozin on cardiac function in patients with type 2 diabetes mellitus: echocardiographic substudy of the EMPA-HEART cardiolink-6 trial 2019 ·European Heart Journal ·(unknown), Sumeet Gandhi, Howard Leong‐Poi, Andrew T. Yan, Edwin Ho, (unknown), Vinay Garg, Hwee Teoh, Adrian Quan, C. David Mazer, Subodh Verma, Géraldine Ong, Kim A. Connelly	1
10	PCSK9 INHIBITION: REAL WORLD APPLICATION AND CHALLENGES TO ACHIEVE UNMET CHOLESTEROL TARGETS IN CANADIAN ATHEROSCLEROTIC HEART DISEASE, THE PRACTICAL STUDY 2018 ·Journal of the American College of Cardiology ·Avinash Pandey, Harpreet S. Bajaj, Vinay Garg, A. Shekhar Pandey, Subodh Verma	1
11	Axillary versus innominate artery cannulation for antegrade cerebral perfusion in aortic surgery: design of the Aortic Surgery Cerebral Protection Evaluation (ACE) CardioLink-3 randomised trial 2017 ·BMJ Open ·Vinay Garg, Mark D. Peterson, Michael Chu, Maral Ouzounian, Roderick MacArthur, John Bozinovski, Ismaı̈l El-Hamamsy, (unknown), Ankit Garg, Judith E. Hall, Kevin E. Thorpe, (unknown), Hwee Teoh, Thomas R. Marotta, David A. Latter, Adrian Quan, Muhammad Mamdani, Peter Jüni, C. David Mazer, Subodh Verma	14
12	The emerging role of proprotein convertase subtilisin/kexin type-9 inhibition in secondary prevention 2017 ·Current Opinion in Cardiology ·A. Shekhar Pandey, Harpreet S. Bajaj, Vinay Garg, (unknown), Subodh Verma	2
13	Advances in aortic disease management 2016 ·Current Opinion in Cardiology ·Vinay Garg, Maral Ouzounian, Mark D. Peterson	3
14	Innominate and Axillary Cannulation in Aortic Arch Surgery Provide Similar Neuroprotection 2015 ·Canadian Journal of Cardiology ·Michael Chu, (unknown), Jill Gelinas, Vinay Garg, (unknown), A. Harrington, Subodh Verma, Mark D. Peterson	19
15	Direct innominate artery cannulation for selective antegrade cerebral perfusion during deep hypothermic circulatory arrest in aortic surgery 2014 ·Journal of Thoracic and Cardiovascular Surgery ·Vinay Garg, (unknown), (unknown), (unknown), David A. Latter, Subodh Verma, Mark D. Peterson	24
16	INNOMINATE ARTERY CANNULATION PROVIDES SIMILAR NEUROPROTECTION TO AXILLARY CANNULATION IN AORTIC ARCH SURGERY AND MAY REDUCE OPERATIVE TIMES 2014 ·Canadian Journal of Cardiology ·Michael Chu, (unknown), Jill Gelinas, Vinay Garg, (unknown), Mark D. Peterson	1
17	miRNA-141 is a novel regulator of BMP-2–mediated calcification in aortic stenosis 2012 ·Journal of Thoracic and Cardiovascular Surgery ·Bobby Yanagawa, Fina Lovren, Yi Pan, Vinay Garg, Adrian Quan, Gilbert H.L. Tang, Krishna K. Singh, Praphulla Chandra Shukla, (unknown), Mark D. Peterson, Subodh Verma	93
18	BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure 2011 ·Journal of Biological Chemistry ·Krishna K. Singh, Praphulla Chandra Shukla, Adrian Quan, Jean‐François Desjardins, Fina Lovren, Yi Pan, Vinay Garg, (unknown), Ankit Garg, Paul E. Szmitko, Michael Schneider, Thomas G. Parker, William L. Stanford, Howard Leong‐Poi, Hwee Teoh, Mohammed Al‐Omran, Subodh Verma	44
19	Serum Enzymes Changes after Death & Its Correlation with Time since Death 2010 ·Journal of Indian Academy of Forensic Medicine ·(unknown), Vinay Garg	1
20	Immediate effect of smoking on serum lipids and lipoproteins in patients with hypertension. 1982 ·SHILAP Revista de lepidopterología ·(unknown), Vinay Garg, (unknown), (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact